Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/3/2026
Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...
4/3/2026
XellSmart Secures CNY 500M+ to Accelerate Parkinson's, ALS and SCI iPS...
4/3/2026
Myeloid Cure Biotech Secures Over CNY 150M in Series A to Advance Mac...
4/3/2026
Recent Executive Moves
4/3/2026
NMPA Suspends Import, Sale and Use of Cadila's Amlodipine Besylate API...
4/3/2026
China's $13B Pharma Boom Drives Growth But Faces Hurdles in US and EU ...
4/2/2026
NMPA Issues Notice on Advancing Segmented Manufacturing of Biologics
4/2/2026
NMPA Releases Implementation Opinions on "AI + Drug Regulation"
4/1/2026
Pierre Fabre Deepens China Commitment as Pharma and Dermo-Cosmetics Gr...
4/1/2026
China Tightens Health Insurance Fund Oversight With New Anti-Fraud Rul...
4/1/2026
Alphamab and CSPC Win Phase III Breast Cancer Success for KN026 Neo-He...
3/31/2026
Simcere Highlights Late-Breaking Phase III Success for Rademikibart in...
3/31/2026
Innovent Publishes Strong Phase II Mazdutide 9 mg Obesity Data as Chin...
3/31/2026
Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...
3/31/2026
Connect Biopharma Reports Promising Late-Stage China Results for Eczem...
3/31/2026
Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...
3/31/2026
NMPA Moves to Strengthen China's Conditional Drug Approval Framework
3/31/2026
NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
3/31/2026
IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing
3/30/2026
GSK's Exdensur Wins China Approval for Severe Eosinophilic Asthma
3/30/2026
AZ/Amgen's Tezspire Wins China Approval for Asthma and CRSwNP
3/30/2026
Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...
3/30/2026
China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...
3/30/2026
BioRay and UCB Win Dual China Dermatology Approvals for Bimzelx
3/30/2026
Enhertu Wins First Global Approval in Neoadjuvant HER2-Positive Early ...
3/27/2026
China Pharma Market Set for Structural Shift as Innovation and Cost Pr...
3/27/2026
GSK Partners Shanghai Pharma to Reintroduce Hepatitis B Vaccine in Chi...
3/27/2026
SK Biopharma Launches Epilepsy Drug Cenobamate in China
3/27/2026
Recent Executive Moves
3/25/2026
Hope Medicine Advances HMI-115 Into Phase III for Endometriosis
Page:
1
/
384
Total number of articles:
11491
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit